Abstract
Skeletal dysplasias are a group of rare genetic disorders that affect growth and development of the skeleton, leading to physical deformities and other medical problems. High-throughput genome sequencing technologies have made it easier to genotype the disorder, but do not always reflect the phenotypic outcome. CHST3-related skeletal dysplasia is caused by the reduced function of the carbohydrate sulfotransferase that sulfates chondroitin sulfate glycosaminoglycans. We show in this pilot study that we were able to phenotype patients with CHST3-related skeletal dysplasia by profiling the glycosaminoglycans and identifying their potential protein carriers sequentially using freezer-induced patient urine sediments.
Funder
Australian Research Council Centre of Excellence in Synthetic Biology
Reference21 articles.
1. Zankl A, Briggs M, Bateman JF. Ch. 27 – Skeletal dysplasias. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T, editors. Genetics of Bone Biology and Skeletal Disease, 2nd edn. Academic Press; 2018. pp. 469–80.
2. Nosology and classification of genetic skeletal disorders: 2019 revision.;Am J Med Genet A,2019
3. Superti-Furga A, Unger S. CHST3-related skeletal dysplasia. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, , editors. GeneReviews((R)). Seattle, WA: University of Washington; 1993. PMID: 21882400
4. Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis.;Am J Hum Genet,2008
5. Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype.;Am J Med Genet A,2008
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SSSMuG: Same Sample Sequential Multi-Glycomics;Analytical Chemistry;2024-02-11
2. Professor Edouard Nice;Australian Journal of Chemistry;2023-08-11